AgomAb Therapeutics NV American Depositary Shares (AGMB) — Long-term Investment Intensity
AgomAb Therapeutics NV American Depositary Shares (AGMB) has a Long-term Investment Intensity of 0.0% as of December 2025. Long-term investments of $11.00K represent 0.0% of total assets of $153.71 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check AGMB cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
AgomAb Therapeutics NV American Depositary Shares Long-term Investment Intensity (2021–2025)
This chart shows how AgomAb Therapeutics NV American Depositary Shares's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the intensity stands at 0.0%, reflecting long-term investments of $11.00K against total assets of $153.71 Million USD. For the complete balance sheet picture, see balance sheet size of AgomAb Therapeutics NV American Deposita.
Annual Long-term Investment Intensity for AgomAb Therapeutics NV American Depositary Shares (2021–2025)
The table below presents the year-by-year Long-term Investment Intensity for AgomAb Therapeutics NV American Depositary Shares from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read AGMB liabilities breakdown for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 0.0% | $11.00K | $153.71 Million | ▲ +0.0 pp |
| 2024 | 0.0% | $12.00K | $206.36 Million | ▼ 0.0 pp |
| 2023 | 0.0% | $14.00K | $171.26 Million | ▼ 0.0 pp |
| 2022 | 0.0% | $14.00K | $101.00 Million | ▼ -0.2 pp |
| 2021 | 0.2% | $147.00K | $84.00 Million | — |